Thus, β-glucan-induced TRIM modulates CD115+CD27high and CD115+ CD27low/− OCPs in a manner that enables them to expand (relative to their counter-parts from untrained mice) upon a secondary challenge (arthritis). Here, CSF1R is linked to arthritic joint disease.